Navigation Links
China-Biotics, Inc. Reports Second Quarter 2009 Financial Results
Date:11/11/2008

SHANGHAI, China, Nov. 11 /Xinhua-PRNewswire-FirstCall/ -- China-Biotics, Inc. (Nasdaq: CHBT) ("China-Biotics", "the Company"), a leading Chinese firm specializing in the manufacture, research, development, marketing and distribution of probiotics products, today announced its financial results for the second quarter of its 2009 fiscal year, ended September 30, 2008.

Second Quarter 2009 Highlights

-- Net sales increased 47.0% year-over-year to $11.5 million

-- Gross profit increased 43.1% year-over-year to $8.0 million

-- Gross margin was 69.9%

-- Net income was $4.5 million

-- Excluding a $1.9 million gain related to the change in fair value of

convertible notes, net income increased 30.4% year over year to $2.6

million

-- Diluted earnings per share was $0.13, compared to $0.11 the prior year

-- Opened 27 retail outlets during the quarter, bringing the total number

of outlets to 110 in 13 cities in China

-- Signed agreement with Henan Square Pharmaceutical Co., Ltd to supply

probiotics for its probiotics-based medicines

-- Began installing equipment for its new manufacturing facility in Qing

Pu Industrial Park in Shanghai

-- Began trading on the Nasdaq Global Market in October

Second Quarter 2009 Results

During the second quarter of the 2009 fiscal year, net sales increased 47.0% to $11.5 million from $7.8 million the prior year, as a result of growth in the sales volume of new products and increases in the sales price of selected products. Sales also benefited from an increase in the number of the Company's Shining retail outlets to 110 from 22 the prior year. New products, including Shining Essence Stomach
'/>"/>

SOURCE China-Biotics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
2. China-Biotics, Inc. Launches Shining Probiotics Protein Powder
3. China-Biotics, Inc. Receives Approval to Begin Construction on Large-Scale Manufacturing Facility
4. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter FY 2008 Results
5. China-Biotics, Inc. Launches English / Chinese Corporate and Investor Relations Web Site
6. China-Biotics, Inc. Announces Rescheduling of Conference Call to Discuss Third Quarter 2008 Results
7. China-Biotics, Inc. Reports Third Quarter 2008 Financial Results
8. China-Biotics, Inc. Completes Foundation for Its New Plant
9. China-Biotics, Inc. to Present at Two Upcoming Investor Conferences
10. China-Biotics, Inc. to Supply Probiotics to Pharmaceutical Company
11. China-Biotics, Inc. Announces Conference Call to Discuss Fourth Quarter and Full Year 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... 2013  Moderna Therapeutics, the pioneering company developing messenger ... the in vivo production of therapeutic proteins, ... will join Moderna in early July as its first ... proven leader in the design and implementation of information ... to translation, clinical operations and commercial preparedness. John has ...
(Date:5/21/2013)... -- The Lindsley F. Kimball Research Institute of the New York ... Challenges Explorations winner, an initiative funded by the ... Lustigman , Head of the Laboratory of Molecular Parasitology ... titled Innovative 3-D in vitro culturing system ... drugs to help eliminate onchocerciasis (river blindness) in ...
(Date:5/21/2013)... new study led by George Washington University Professor ... of ice in small droplets is strongly size-dependent, ... the nanoscale. The formation of ice at the ... whose answer also has important implications for climate ... of ice from supercooled water is generally initiated ...
(Date:5/21/2013)... Branchburg, NJ (PRWEB) May 21, 2013 ... enhancement industry, has appointed Dale Braddy to Southeastern USA ... proactively bolster its sales muscle in the Southeast. ... a food ingredient brokerage and supplier to food processors ... past 13 years in the food industry and has ...
Breaking Biology Technology:Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 2Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 3New York Blood Center's Research Institute Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development 2New York Blood Center's Research Institute Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development 3Study led by GW professor provides better understanding of water's freezing behavior at nanoscale 2
... Pharmaceutical Manufacturing and Biotechnology Middle East (PABME) 27-29 ... ... The Middle East,market for pharmaceutical manufacturing and biotechnology, already valued,at over US$ ... -- Dubai is the commercial, scientific and financial center of the ...
... Conference Call to be Held on September 6, 2007 ... / 5:00 am (Pacific) / 8:00 pm (Beijing/Hong Kong), ... Inc. (NYSE: WX ) ("WuXi PharmaTech" or ,the ... outsourcing company, today announced that it will release,unaudited financial ...
... Reduced Tumor Growth by ... - Findings Confirm Key Aspects of Bavituximab,s Mechanism of Action in ... Combination with Radiation Therapy -, - Results Further Support Future Clinical Trials ... Combination With Radiation Therapy -, TUSTIN, Calif., ...
Cached Biology Technology:WuXi PharmaTech Schedules 2007 Second Quarter Earnings Release on Thursday, September 6, 2007 2WuXi PharmaTech Schedules 2007 Second Quarter Earnings Release on Thursday, September 6, 2007 3Study Published in Clinical Cancer Research Confirms Potential Of Peregrine's Bavituximab Combined With Radiation In Lung Cancer 2Study Published in Clinical Cancer Research Confirms Potential Of Peregrine's Bavituximab Combined With Radiation In Lung Cancer 3Study Published in Clinical Cancer Research Confirms Potential Of Peregrine's Bavituximab Combined With Radiation In Lung Cancer 4Study Published in Clinical Cancer Research Confirms Potential Of Peregrine's Bavituximab Combined With Radiation In Lung Cancer 5
(Date:5/21/2013)... experts , Where? Copenhagen, Denmark: Bella ... June 2013 , Why? An ... and policy developments, manufacturing and installation, drawing on leading ... its 2013 edition from a record of more than ... than 240 plenary and oral presentations, more than 460 ...
(Date:5/21/2013)... ANDOVER, Mass. , May 21, 2013 ... that CX50 xMATRIX, the world,s first portable ultrasound with ... Intracardiac Echo (ICE) capability. The CX50 xMATRIX with available ... Paris at the EuroPCR, official ... (EAPCI), May 21-24. Since its launch in ...
(Date:5/20/2013)... Bacteria resistant to the antibiotic colistin are also ... human body, according to a study in ... American Society for Microbiology. Cross-resistance to colistin and ... the body against bacterial attack, could mean that ... saddled with a crippled immune response. Colistin is ...
Breaking Biology News(10 mins):21st European Biomass Conference and Exhibition 221st European Biomass Conference and Exhibition 321st European Biomass Conference and Exhibition 4Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 3
... to play a pivotal role in the inception of Darwin’s ... of their significance when he collected them during his voyage ... to predict the impact the vast amount of marine microbial ... by J. Craig Venter, Ph.D., and his team ?will have ...
... fixed nitrogen, the building block of life, after all. Instead, ... twice the amount of nitrogen fixing as the Atlantic, say ... title of an accompanying News and Views piece says it ... , It's important to have a global picture ...
... to many of the same health problems as tobacco smoke, ... according to a new study by researchers at Yale School ... illicit drug in the United States, and abuse of the ... today's Archives of Internal Medicine. First author Jeanette M. Tetrault, ...
Cached Biology News:Darwin's famous finches and Venter's marine microbes 2Darwin's famous finches and Venter's marine microbes 3Darwin's famous finches and Venter's marine microbes 4Darwin's famous finches and Venter's marine microbes 5New findings blow a decade of assumptions out of the water 2New findings blow a decade of assumptions out of the water 3Migration played key role in HIV spread in South Africa 2
... Complete kit for all types of yeast ... Choice of two ... self-activating baits , ... , Complete set ...
interferon-related developmental regulator 2...
Mouse Limitin MAb (Clone 183727)...
Human Serum FDA Licensed US Donor Centers Sterile / Non-sterile: Sterile Filtered to 0.2 micron Information: Extensive Viral Testing ...
Biology Products: